Stephen Hanauer

About

Stephen Hanauer is a Professor of Medicine at Northwestern University in Chicago, USA. His research focuses on inflammatory bowel disease, particularly in areas such as precision-guided dosing, the efficacy and safety of biological therapies, and the impact of genetic polymorphisms on treatment outcomes. He has contributed to the field through multiple recent articles that examine optimization strategies for treatments like infliximab and adalimumab, as well as dietary considerations in managing Crohn’s disease.